D. S. Dias

发表

Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis

R. Machado-de-Ávila, Lívia M. Carvalho, B. M. Roatt, 2020, Vaccines.

Evaluation of the protective efficacy of a Leishmania protein associated with distinct adjuvants against visceral leishmaniasis and in vitro immunogenicity in human cells

D. Menezes-Souza, R. Machado-de-Ávila, Lívia M. Carvalho, 2020, Parasitology Research.

Immunogenicity and protective efficacy of a new Leishmania hypothetical protein applied as a DNA vaccine or in a recombinant form against Leishmania infantum infection.

D. Menezes-Souza, D. Gomes, B. M. Roatt, 2019, Molecular immunology.

A Leishmania hypothetical protein‐containing liposome‐based formulation is highly immunogenic and induces protection against visceral leishmaniasis

D. Menezes-Souza, B. M. Roatt, Grasiele S. V. Tavares, 2018, Cytokine.

In silico Leishmania proteome mining applied to identify drug target potential to be used to treat against visceral and tegumentary leishmaniasis.

Grasiele S. V. Tavares, D. V. Mendonça, D. P. Lage, 2019, Journal of molecular graphics & modelling.

Small Myristoylated Protein-3, Identified as a Potential Virulence Factor in Leishmania amazonensis, Proves to be a Protective Antigen against Visceral Leishmaniasis

R. Machado-de-Ávila, F. Ramos, D. P. Lage, 2018, International journal of molecular sciences.

A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection

R. Machado-de-Ávila, L. Perin, Lívia M. Carvalho, 2020, npj Vaccines.

A chloroquinoline derivate presents effective in vitro and in vivo antileishmanial activity against Leishmania species that cause tegumentary and visceral leishmaniasis.

E. S. Coimbra, V. Nobre, L. Perin, 2019, Parasitology international.

In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic® F127-based polymeric micelle system against Leishmania amazonensis infection.

R. J. Alves, E. S. Coimbra, D. Menezes-Souza, 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection

D. Menezes-Souza, L. Goulart, P. T. Alves, 2017, Parasites & Vectors.

A Pluronic® F127-based polymeric micelle system containing an antileishmanial molecule is immunotherapeutic and effective in the treatment against Leishmania amazonensis infection.

R. J. Alves, E. S. Coimbra, D. Menezes-Souza, 2019, Parasitology international.

Serological diagnosis and prognostic of tegumentary and visceral leishmaniasis using a conserved Leishmania hypothetical protein.

D. Menezes-Souza, F. Ramos, D. P. Lage, 2018, Parasitology international.

Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis.

D. Menezes-Souza, B. M. Roatt, D. V. Mendonça, 2018, Experimental parasitology.

Diagnostic markers selected by immunoproteomics and phage display applied for the serodiagnosis of canine leishmaniosis.

Grasiele S. V. Tavares, João A. Oliveira-da-Silva, D. P. Lage, 2019, Research in veterinary science.

S0031182018001403jra 322..332

D. Menezes-Souza, L. Goulart, P. T. Alves, 2019 .

High-through identification of T cell-specific phage-exposed mimotopes using PBMCs from tegumentary leishmaniasis patients and their use as vaccine candidates against Leishmania amazonensis infection

D. Menezes-Souza, L. Goulart, P. T. Alves, 2018, Parasitology.

S0031182017001731jra 740..751

D. Menezes-Souza, D. Gomes, Grasiele S. V. Tavares, 2018 .

Antigenicity, immunogenicity and protective efficacy of a conserved Leishmania hypothetical protein against visceral leishmaniasis

D. Menezes-Souza, D. Gomes, Grasiele S. V. Tavares, 2017, Parasitology.

Probing the efficacy of a heterologous Leishmania/L. Viannia braziliensis recombinant enolase as a candidate vaccine to restrict the development of L. infantum in BALB/c mice.

D. Menezes-Souza, R. Machado-de-Ávila, B. M. Roatt, 2017, Acta tropica.

A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-up.

R. Fujiwara, L. Bueno, R. Machado-de-Ávila, 2018, Diagnostic microbiology and infectious disease.

Recombinant small glutamine‐rich tetratricopeptide repeat‐containing protein of Leishmania infantum: Potential vaccine and diagnostic application against visceral leishmaniasis

D. Menezes-Souza, R. Machado-de-Ávila, B. M. Roatt, 2017, Molecular immunology.

Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasis.

R. Machado-de-Ávila, F. Ramos, D. P. Lage, 2019, Immunobiology.

Diagnostic evaluation of the amastin protein from Leishmania infantum in canine and human visceral leishmaniasis and immunogenicity in human cells derived from patients and healthy controls.

R. Machado-de-Ávila, Grasiele S. V. Tavares, F. Ramos, 2019, Diagnostic microbiology and infectious disease.

Recombinant prohibitin protein of Leishmania infantum acts as a vaccine candidate and diagnostic marker against visceral leishmaniasis.

D. Menezes-Souza, R. Machado-de-Ávila, B. M. Roatt, 2017, Cellular immunology.

Diagnostic application of recombinant Leishmania proteins and evaluation of their in vitro immunogenicity after stimulation of immune cells collected from tegumentary leishmaniasis patients and healthy individuals.

D. Menezes-Souza, R. Machado-de-Ávila, F. Ramos, 2018, Cellular immunology.

Vaccination with a CD4+ and CD8+ T‐cell epitopes‐based recombinant chimeric protein derived from Leishmania infantum proteins confers protective immunity against visceral leishmaniasis

D. Menezes-Souza, T. Mendes, B. M. Roatt, 2018, Translational research : the journal of laboratory and clinical medicine.

Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.

E. S. Coimbra, L. Perin, Grasiele S. V. Tavares, 2019, Experimental parasitology.

rMELEISH: A Novel Recombinant Multiepitope-Based Protein Applied to the Serodiagnosis of Both Canine and Human Visceral Leishmaniasis

F. Ramos, A. S. Machado, E. Coelho, 2023, Pathogens.

Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis.

D. Menezes-Souza, R. Machado-de-Ávila, Lívia M. Carvalho, 2020, Cytokine.

A biomarker for tegumentary and visceral leishmaniasis based on a recombinant Leishmania hypothetical protein.

D. Menezes-Souza, R. Machado-de-Ávila, Grasiele S. V. Tavares, 2019, Immunobiology.

Screening diagnostic candidates from Leishmania infantum proteins for human visceral leishmaniasis using an immunoproteomics approach

M. O. Rocha, Grasiele S. V. Tavares, F. Ramos, 2019, Parasitology.

In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.

E. S. Coimbra, Grasiele S. V. Tavares, D. V. Mendonça, 2019, Acta tropica.

S0031182019000714jra 1467..1476

M. O. Rocha, Grasiele S. V. Tavares, F. Ramos, 2019 .

Evaluation of a Leishmania hypothetical protein administered as DNA vaccine or recombinant protein against Leishmania infantum infection and its immunogenicity in humans.

D. Menezes-Souza, R. Machado-de-Ávila, B. M. Roatt, 2018, Cellular immunology.

Performance of Leishmania braziliensis enolase protein for the serodiagnosis of canine and human visceral leishmaniosis.

D. Menezes-Souza, R. Machado-de-Ávila, B. M. Roatt, 2017, Veterinary parasitology.

Immunodiagnosis of human and canine visceral leishmaniasis using recombinant Leishmania infantum Prohibitin protein and a synthetic peptide containing its conformational B-cell epitope.

B. M. Roatt, F. Ramos, Fernanda Ludolf, 2019, Journal of immunological methods.

Selection strategy of phage-displayed immunogens based on an in vitro evaluation of the Th1 response of PBMCs and their potential use as a vaccine against Leishmania infantum infection

D. Menezes-Souza, L. Goulart, P. T. Alves, 2017, Parasites & Vectors.